Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.44 |
| ▸ | PPARA | Q07869 | 4/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5660233 | 0.87 | PPARG (0.66) | PPARGPPARA | |
| SCHEMBL14526666 | 0.87 | PPARA (0.40) | F2PPARAALDH1A1 | |
| SCHEMBL14526667 | 0.84 | PPARA (0.41) | PPARGF2PPARAALDH1A1 | |
| SCHEMBL5660596 | 0.84 | PPARG (0.53) | PPARGF2PPARA | |
| SCHEMBL14526665 | 0.78 | PPARA (0.43) | PPARGPPARAALDH1A1 | |
| SCHEMBL14584573 | 0.75 | PPARG (0.70) | PPARGPPARA | |
| SCHEMBL5751917 | 0.74 | KDM4E (0.46) | PPARGPPARAFFAR1ALDH1A1 | |
| SCHEMBL5660220 | 0.74 | CA1 (0.42) | F2ALDH1A1 | |
| SCHEMBL5660178 | 0.73 | PPARA (0.53) | PPARGPPARA | |
| SCHEMBL5659854 | 0.73 | PPARG (0.61) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070093476-A1 | Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them | DR. REDDY'S LABORATORIES LIMITED (IN) | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093476-A1 | Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them | GPR119, NR1H3, NR1H2 | PPARG 170/4885F2 3263/4885PPARA 251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.